Abstract 6182: The E3 Ubiquitin Ligase Hrd1 Promotes Aortic Aneurysm/Dissection Formation by Regulating Macrophage Efferocytosis
Abstract
Background: Aortic aneurysm/dissection (AAD) is a life-threatening cardiovascular disease with limited pharmacological treatment. Macrophage efferocytosis is essential for clearing apoptotic cells and maintaining aortic wall homeostasis. However, the upstream molecular regulators that impair macrophage efferocytosis during AAD remain unclear. Protein ubiquitination is a key post-translational mechanism controlling diverse cardiovascular and immune processes. We investigated whether the E3 ubiquitin ligase Hrd1 contributes to AAD through macrophage-dependent regulation. Methods: Single-cell RNA sequencing analysis of human aortic tissues was used to screen AAD-associated E3 ubiquitin ligases enriched in macrophages. Hrd1 expression was further examined in mice AAD aortas by molecular approaches. To define its functional role, macrophage-specific Hrd1-deficient mice and littermate controls were subjected to β-aminopropionitrile (BAPN)-induced AAD. Survival, AAD formation, aortic dilation, and aortic wall pathology were assessed. Bone marrow-derived macrophages (BMDMs) from Hrd1 fl/fl and Hrd1 fl/fl ;LysM Cre mice were subjected to systematic functional analyses to assess the impact of Hrd1 deficiency on core macrophage functions. Results: Hrd1 was increased in AAD aortas from experimental mice, with predominant enrichment in macrophages. Macrophage-specific Hrd1 deletion reduced AAD-related mortality after BAPN challenge. Ultrasound analysis showed reduced aortic dilation in Hrd1 fl/fl ;LysM Cre mice compared with Hrd1 fl/fl controls, while histological assessment by HE and EVG staining revealed better preservation of aortic wall architecture and elastic fiber integrity. Functional analyses of BMDMs indicated that Hrd1 deficiency selectively improved macrophage capacity to clear apoptotic cells, whereas other major macrophage functional phenotypes were not broadly altered. Conclusion: These findings identify macrophage Hrd1 as a disease-promoting regulator in AAD. Based on the current results, Hrd1 appears to contribute to AAD progression primarily by impairing a protective macrophage function required for the clearance of apoptotic cells, rather than by globally reshaping macrophage activation. Targeting Hrd1-dependent macrophage dysfunction may provide a potential strategy to preserve aortic wall homeostasis and limit AAD progression.